Clinical Trials Browser

Completed × Mouth Neoplasms × Observation × Clear all

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts

Mouth Neoplasms